• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stem Cell-derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?

作者信息

Goncharova Elena A, Farkas Laszlo

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine University of California, Davis School of Medicine Davis, California.

Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus, Ohio.

出版信息

Am J Respir Cell Mol Biol. 2022 Jul;67(1):3-5. doi: 10.1165/rcmb.2022-0078ED.

DOI:10.1165/rcmb.2022-0078ED
PMID:35522729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9273228/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/9273228/2a03e87bcef3/rcmb.2022-0078EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/9273228/2a03e87bcef3/rcmb.2022-0078EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/9273228/2a03e87bcef3/rcmb.2022-0078EDf1.jpg

相似文献

1
Stem Cell-derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?用于治疗肺动脉高压的干细胞衍生纳米囊泡：我们成功了吗？
Am J Respir Cell Mol Biol. 2022 Jul;67(1):3-5. doi: 10.1165/rcmb.2022-0078ED.
2
Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.间质干细胞衍生的纳米囊泡作为肺动脉高压治疗的可信因子。
Am J Respir Cell Mol Biol. 2022 Jul;67(1):61-75. doi: 10.1165/rcmb.2021-0415OC.
3
Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.间质干细胞细胞外囊泡逆转沙利度胺/缺氧诱导的大鼠肺动脉高压。
Am J Respir Cell Mol Biol. 2020 May;62(5):577-587. doi: 10.1165/rcmb.2019-0154OC.
4
Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer.由诱导多能干细胞衍生的间充质干细胞制成的细胞外囊泡模拟物可改善转移性前列腺癌的治疗。
Stem Cell Res Ther. 2021 Jan 7;12(1):29. doi: 10.1186/s13287-020-02097-5.
5
Extracellular vesicles in pulmonary hypertension: lessons from mesenchymal stromal cell-derived exosomes.肺动脉高压中的细胞外囊泡：间充质基质细胞衍生外泌体的启示
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L720-L722. doi: 10.1152/ajplung.00107.2019. Epub 2019 Mar 13.
6
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?巨噬细胞免疫调节：骨髓间充质干细胞衍生外泌体在肺动脉高压中的“守门员”？
Int J Mol Sci. 2018 Aug 27;19(9):2534. doi: 10.3390/ijms19092534.
7
Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.间质干细胞移植通过使内皮细胞向间充质转化正常化来减轻肺动脉高压。
Am J Respir Cell Mol Biol. 2020 Jan;62(1):49-60. doi: 10.1165/rcmb.2018-0165OC.
8
Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.外泌体介导间充质基质细胞对低氧诱导性肺动脉高压的保护作用。
Circulation. 2012 Nov 27;126(22):2601-11. doi: 10.1161/CIRCULATIONAHA.112.114173. Epub 2012 Oct 31.
9
The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.用1-磷酸鞘氨醇预处理的人间充质干细胞对肺动脉高压的治疗作用
Stem Cells Dev. 2015 Jul 15;24(14):1658-71. doi: 10.1089/scd.2014.0496. Epub 2015 Apr 9.
10
GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension.GAPDH 对于女性骨髓间充质干细胞在肺动脉高压中的优越疗效至关重要。
Cardiovasc Res. 2013 Oct 1;100(1):19-27. doi: 10.1093/cvr/cvt165. Epub 2013 Jun 25.

引用本文的文献

1
Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology.肿瘤细胞外囊泡蛋白作为精准肿瘤学的新型生物标志物和治疗靶点。
J Mol Med (Berl). 2024 Aug;102(8):961-971. doi: 10.1007/s00109-024-02452-6. Epub 2024 May 30.

本文引用的文献

1
Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.间质干细胞衍生的纳米囊泡作为肺动脉高压治疗的可信因子。
Am J Respir Cell Mol Biol. 2022 Jul;67(1):61-75. doi: 10.1165/rcmb.2021-0415OC.
2
Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells.细胞外囊泡通过对髓样细胞的表观遗传和转录组重编程来保护新生肺免于高氧损伤。
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1418-1432. doi: 10.1164/rccm.202102-0329OC.
3
Endothelial cells in the pathogenesis of pulmonary arterial hypertension.
肺动脉高压发病机制中的内皮细胞
Eur Respir J. 2021 Sep 2;58(3). doi: 10.1183/13993003.03957-2020. Print 2021 Sep.
4
Extracellular Vesicles Attenuate Nitrofen-Mediated Human Pulmonary Artery Endothelial Dysfunction: Implications for Congenital Diaphragmatic Hernia.细胞外囊泡减轻了地高辛诱导的人肺动脉内皮功能障碍：先天性膈疝的启示。
Stem Cells Dev. 2020 Aug 1;29(15):967-980. doi: 10.1089/scd.2020.0063. Epub 2020 Jun 27.
5
Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.间质干细胞细胞外囊泡逆转沙利度胺/缺氧诱导的大鼠肺动脉高压。
Am J Respir Cell Mol Biol. 2020 May;62(5):577-587. doi: 10.1165/rcmb.2019-0154OC.
6
Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.间质基质细胞外泌体通过调节单核细胞表型预防和逆转实验性肺纤维化。
JCI Insight. 2019 Nov 1;4(21):128060. doi: 10.1172/jci.insight.128060.
7
Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.间质干细胞/基质细胞治疗肺动脉高压：临床前研究的综合综述。
J Cardiol. 2019 Oct;74(4):304-312. doi: 10.1016/j.jjcc.2019.04.006. Epub 2019 May 18.
8
Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency.迈向基于外泌体的疗法：分离、异质性及适用于特定用途的效力
Front Cardiovasc Med. 2017 Oct 9;4:63. doi: 10.3389/fcvm.2017.00063. eCollection 2017.
9
Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.肺动脉高压领域的转化医学进展。肺动脉高压中微小RNA生物学的转化。这需要的不仅仅是“miR”这个词。
Am J Respir Crit Care Med. 2017 Jan 15;195(2):167-178. doi: 10.1164/rccm.201604-0886PP.
10
Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.肺动脉高压领域的转化研究进展。从癌症生物学到新的肺动脉高压治疗方法。靶向细胞生长和增殖信号枢纽。
Am J Respir Crit Care Med. 2017 Feb 15;195(4):425-437. doi: 10.1164/rccm.201606-1226PP.